Thyroxine uptake by human hepatoma cells from serum of patients submitted to long-term thyroxine suppressive therapy

scientific article published on 01 October 1988

Thyroxine uptake by human hepatoma cells from serum of patients submitted to long-term thyroxine suppressive therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023099364
P356DOI10.1007/BF03350199
P698PubMed publication ID2851621

P2093author name stringA Pinchera
E Martino
M Falcone
L Bartalena
A Pacchiarotti
P2860cites workHormonal influences on the secretion of steroid-binding proteins by a human hepatoma-derived cell lineQ72393758
'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individualsQ93594533
Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.Q34556047
Suppression of the TSH response to TRH by thyroxine therapy in differentiated thyroid carcinoma patientsQ39674580
TRH Test as an Index of Suppression Compared with the Thyroid Radioiodine Uptake in Euthyroid Goitrous Patients Treated with Thyroxine*Q39724843
Clinical evaluation of free T4 techniques.Q39761771
Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implicationsQ39868994
Chemical hyperthyroidism: serum triiodothyronine levels in clinically euthyroid individuals treated with levothyroxineQ40339643
The Effect of Suppressive Therapy of Nontoxic Diffuse Goiter on Serum Levels of Thyroxine, 3,5,3‘-Triiodothyronine and 3,3’,5‘-TriiodothyronineQ40585202
The Comparative Effect of T4and T3on the TSH Response to TRH in Young Adult MenQ41229621
Serum thyroid hormone levels in patients on thyroxine replacement therapyQ41819772
Serum thyroxine levels in patients receiving L-thyroxine suppression or replacement therapyQ41861923
Human serum thyrotrophin measurement by ultrasensitive immunoradiometric assay as a first-line test in the evaluation of thyroid functionQ42511147
Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assayQ42511259
Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patientsQ42526663
Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".Q43010849
Characterization of nascent and secreted thyroxine-binding globulin in cultured human hepatoma (Hep G2) cellsQ43712395
Measurement of thyroxine uptake from serum by cultured human hepatocytes as an index of thyroid status: reduced thyroxine uptake from serum of patients with nonthyroidal illnessQ43716765
Sex hormone-binding protein in hyperthyroxinemic patients: a discriminator for thyroid status in thyroid hormone resistance and familial dysalbuminemic hyperthyroxinemia.Q54427549
Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassayQ66943700
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxineQ69106089
Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disordersQ69448167
Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxineQ70404513
Studies of the protein binding of testosterone in plasma in disorders of thyroid function: effect of therapyQ71570541
P433issue9
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)629-635
P577publication date1988-10-01
P1433published inJournal of Endocrinological InvestigationQ15766847
P1476titleThyroxine uptake by human hepatoma cells from serum of patients submitted to long-term thyroxine suppressive therapy
P478volume11

Search more.